28th Sep 2016 10:41
LONDON (Alliance News) - Allergy vaccines developer Allergy Therapeutics PLC Wednesday said Finance Director Nick Wykeman bought 150,000 shares at a price of 17.75 pence per share on Tuesday.
The purchase is Wykeman's only holding after being appointed in June.
The stock was up 9.4% at 19.41p Wednesday.
By Arvind Bhunjun; [email protected]; @ArvindBhunjun
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Allergy Thera.